# Patient Health Summary
**Patient:** Doug Langille  
**Age:** 53 years old  
**Height:** 5'9"  
**Weight:** 315 lbs (January 9, 2026)  
**BMI:** ~46.5  
**Location:** Hardwood Lands, Nova Scotia, Canada  
**Last Updated:** January 12, 2026

**Primary Care:** Dr. Shikhi Phimsharma (Shikhi Sharma), Colchester Regional Hospital  
**Specialist:** Dr. Peter Alexander Massaro (Urology/Hormone Management)

**Neurodivergence:** Self-assessed autistic with ADHD traits (Asperger's cluster)

---

## Diagnosed Conditions

### Cardiovascular & Metabolic
1. **Hypertension** - Active, under treatment
   - Medication: Telmisartan HCTZ 80/25mg daily (started Jan 9, 2026)
   - Status: Slightly elevated but managed

2. **Type 2 Diabetes** - Active, prediabetic progressing toward diabetes ‚ö†Ô∏è URGENT
   - **HbA1c:** 6.9% (Dec 2025) ‚¨ÜÔ∏è from 6.5% (Sept 2025)
   - **Fasting glucose:** 8.9 mmol/L (significantly elevated, normal <6.0)
   - **Treatment:** 
     - Metformin ER 1000mg daily (started Jan 9, 2026)
     - Ozempic 0.25-0.5mg weekly injection (starting Jan 13, 2026)
   - **Complication:** Early microalbuminuria (urine albumin 22.7 mg/L, normal <20)
   - **Insurance:** Blue Cross (Ozempic approved)

3. **High Cholesterol (Hyperlipidemia)** - Active
   - **LDL:** 3.02 mmol/L (target <2.6)
   - **Total Cholesterol:** 4.66 mmol/L (normal range)
   - **Triglycerides:** 1.49 mmol/L (normal)
   - **Medication:** Rosuvastatin 10mg daily (started Jan 9, 2026)

### Respiratory & Sleep
4. **Sleep Apnea** - Active, well-managed
   - **Treatment:** CPAP for 7 years
   - **Effectiveness:** Near-zero apnea events
   - **Sleep Duration:** 5-6 hours actual (in bed 7 hours: 11pm-6am)
   - **Issue:** Sleep debt despite good architecture
   - **Note:** May need CPAP pressure adjustment as weight decreases

### Endocrine & Metabolic
5. **Low Testosterone (Hypogonadism)** - Active, under TRT
   - **Medication:** Testosterone Enanthate 150mg (0.75mL of 200mg/mL) IM every 2 weeks
   - **Duration:** 7 years
   - **Prescriber:** Dr. Peter Massaro
   - **Monitoring:** PSA and prostate exam every 6 months
   - **Paradox:** March 2025 bioavailable testosterone 22.71 nmol/L (normal 2.5-10)
   - **Note:** High reading likely due to injection timing; to be reviewed Spring 2026
   - **Consideration:** May need TRT dose adjustment as weight decreases

### Musculoskeletal & Rheumatic
6. **Gout** - Active, under prevention
   - **Medication:** Allopurinol 200mg daily (started Jan 9, 2026)
   - **Risk:** Rapid weight loss can temporarily increase uric acid
   - **Monitoring:** Joint pain, especially feet/toes
   - **Action plan:** Contact Dr. Sharma if flares occur (may adjust allopurinol dose)

---

## Current Medications (6 Total)

### Daily Oral Medications (4)
All started January 9, 2026:
- **Rosuvastatin** 10mg - Cholesterol (DIN: 02411636)
- **Telmisartan HCTZ** 80/25mg - Blood pressure (DIN: 02390310)
- **Metformin ER** 1000mg - Blood sugar (DIN: 02460653)
- **Allopurinol** 200mg - Gout prevention (DIN: 02396335)

### Injectable Medications (2)
- **Ozempic (Semaglutide)** 0.25-0.5mg weekly subcutaneous (DIN: 02540258)
  - **First dose:** January 13, 2026 (Monday evening after darts)
  - **Schedule:** Monday evenings (allows worst side effects Tue-Wed, clears weekends)
  - **Location:** Abdomen preferred (rotate injection sites)
  - **Dose titration:** 0.25mg x 4 weeks, then increase pending tolerance

- **Testosterone Enanthate** 150mg IM every 2 weeks (DIN: 02536315)
  - Ongoing since 2019, prescribed by Dr. Massaro

### Supplements
- **Vitamin D** (daily)
- **Over-50 Multivitamin** from Costco (currently out of stock - need to restock)

---

## Recent Bloodwork Trends

### September ‚Üí December 2025 (3.5-month window)

#### üî¥ Deteriorating
- **HbA1c:** 6.5% ‚Üí 6.9% (+0.4%) - Approaching diabetic threshold of 7.0%
- **Urine Albumin:** 7.5 ‚Üí 22.7 mg/L (+203%) - Now above normal, early kidney stress
- **Fasting Glucose:** 8.9 mmol/L - Significantly elevated (normal <6.0)

#### ‚úÖ Stable/Positive
- **eGFR:** 81 ‚Üí 83 - Excellent kidney filtration (+2 improvement)
- **Electrolytes:** All normal and stable
- **PSA:** 0.82 (March 2025) - Excellent prostate health
- **Blood Counts:** All normal (March 2025)

**Clinical Significance:** 3.5-month metabolic deterioration without medication prompted comprehensive 5-drug regimen January 9, 2026.

---

## Lifestyle & Baseline Assessment

### Physical Activity
- **Occupation:** IT Manager, NSCC (sedentary desk work)
- **Daily Activity:** Fairly active on hobby farm despite sedentary job
- **Steps:**
  - Winter: 7,000-10,000 daily
  - Non-winter: Consistently >10,000 daily
- **Farm Work:** Functional resistance training (carrying feed, mucking stalls, lifting hay, pushing wheelbarrows, fence work)
- **Tracking:** Fitbit device

### Energy & Sleep
- **Pattern:** Generally tired all day
- **Sleep Schedule:** In bed 11pm, wake 6am (7-hour window)
- **Actual Sleep:** 5-6 hours (Fitbit tracking)
- **Quality:** Good architecture with CPAP; near-zero apnea events
- **Issue:** Sleep duration deficit contributing to fatigue and insulin resistance

### Eating Patterns
- **Breakfast:** Decent - eggs and something (protein foundation)
- **Lunch:** Typically carb-heavy
- **Dinner:** Full meal
- **Snacking:** Throughout the day; quality subpar
- **Evening Snacking:** Sporadic; sometimes heavy, sometimes not
- **Assessment:** Carb-heavy lunch + all-day snacking likely driving weight gain and HbA1c increase

### Beverage Consumption
- **Coffee:** ~1 pot of black coffee daily (no cream, no sugar)
- **Evening:** Switches to tea (hot beverage preference)
- **Hydration Note:** Coffee counts partially but has diuretic effect; prioritize plain water for Ozempic therapy (1.5-2L daily target)

### Weight History
- Autumn 2025: ~305-310 lbs
- January 9, 2026: **315 lbs** (doctor's scale)
- Recent gain attributed to holiday season

---

## Health Goals & Treatment Strategy

### Primary Goals
1. **Glycemic Control** - Lower HbA1c from 6.9% to <6.0% (target: below 7.0% minimum)
2. **Weight Loss** - Reduce overall weight to improve metabolic health
3. **Increased Healthspan** - Living longer and healthier
4. **Improved Energy** - Address chronic fatigue

### Expected Ozempic Benefits
**Primary:**
- HbA1c reduction of 1-2% over 3-6 months
- Weight loss 5-15% body weight typical
- Improved fasting glucose
- Reduced appetite

**Secondary cascade effects from weight loss:**
- Reduced blood pressure
- Improved cholesterol profile
- Decreased gout risk
- Improved libido
- Potential reduction in sleep apnea severity (may need CPAP adjustment)
- Possible improvement in natural testosterone (may need TRT adjustment)

### Hypothesis
Weight is primary driver of interconnected health issues (hypertension, cholesterol, diabetes, gout, lagging libido). Weight loss should create positive cascade effects across all conditions.

---

## Ozempic Therapy Protocol

### Dosing Schedule
**Phase 1 (Weeks 1-4):** 0.25mg weekly - January 13 to February 9, 2026  
**Phase 2:** Increase after 4 weeks pending tolerance check  
**Pen Supply:** Single pen provides ~2 months

### Injection Protocol
- **Day/Time:** Monday evenings after darts
- **Rationale:** Side effects peak 1-2 days post-injection; Monday dosing = worst symptoms Tue-Wed, weekends clear
- **Location:** Abdomen preferred (better absorption, less painful than thighs)
- **Rotation Pattern:**
  1. Start bottom right abdomen (>2 inches from belly button)
  2. Move over 1-2 inches each week
  3. Switch to left side after 2 injections
  4. Move up above belly button line
  5. Continue rotation, then reset
- **Storage:** Refrigerate; stable 56 days room temperature if needed

### Managing Side Effects (Tina Buchner's Practical Advice)

**1. Never Overeat**
- If full, push plate away even with food remaining
- Risk: Severe heartburn and reflux if ignored

**2. Hydration is Imperative**
- Target: 1.5-2L water daily minimum
- Risk: Constipation, potential bowel obstruction
- Action: If no bowel movement entire day, take Milk of Magnesia
- Note: Most get constipation rather than diarrhea

**3. Combat Nausea**
- Drug slows digestive tract significantly
- Keep crackers on hand at all times
- Don't let yourself get too hungry
- Appetite suppression is strong, but hunger window is short

**4. Protein is Key**
- Target: 60-150g protein daily
- Risk: Muscle wasting without adequate protein
- Strategies:
  - Protein shake after morning coffee (Fairlife from Costco.ca)
  - Keep almonds and walnuts for protein hits
  - Avoid deli meat (high nitrates, sodium)

**5. Expected Changes**
- Cravings will likely stop
- Taste changes - some foods become unappealing
- May shift from carbs to preferring meat/vegetables
- Snacking may naturally decrease or eliminate
- Coffee/tea preferences may shift

**6. Timeline**
- ~4 months to stabilize on therapeutic dose
- Side effects may diminish or disappear after settling
- Variable response - some have no side effects
- 20% of people don't lose weight (but still get glycemic control)

---

## Key Monitoring Priorities

### Gout Risk (Primary Concern)
Rapid weight loss can temporarily increase uric acid levels
- **Monitor:** Joint pain, especially feet/toes
- **Mitigation:** Maintain allopurinol, aggressive hydration
- **Action:** Contact Dr. Sharma if flares occur

### Muscle Loss Prevention
GLP-1 therapy can cause muscle wasting without adequate protein
- **Monitor:** Strength during farm activities, Fitbit activity levels
- **Mitigation:** High protein (60-150g daily), maintain/increase resistance activities
- **Consider:** Bodyweight exercises (push-ups, squats, planks)

### GI Management
- **Monitor:** Bowel movements, nausea, appetite, comfort
- **Mitigation:** Follow Tina's advice (see above)
- **Note:** Unlike Xenical, Ozempic does NOT cause uncontrollable oily discharge

### Secondary Monitoring
- Energy levels (especially weeks 1-6)
- Sleep quality/duration
- Blood pressure readings
- Libido changes
- Appetite and food preference shifts
- Weight trends
- Activity level maintenance

---

## Tracking Strategy: Neurodivergent-Sustainable Approach

### The Perfection Trap Problem
Autistic systemizing drive + ADHD executive function challenges = "perfect tracking or no tracking" ‚Üí system collapse

### Pragmatic Compromise: Outcome-Based Tracking

**Weekly Check-ins (Mondays before injection):**
- Weight (track trend, not daily fluctuation)
- Notable side effects this week
- Gout symptoms or joint pain?
- Energy level (better/same/worse)
- Bowel movement pattern

**Quarterly Medical Tracking:**
- HbA1c results (primary success metric)
- Blood pressure
- Medication changes
- Doctor feedback

**Protein Awareness (Not Counting):**
- Protein at breakfast? (yes/no - already doing eggs)
- Protein shake or high-protein snack? (yes/no)
- **Awareness, not rigid counting**

**"Trust the Process" Indicators:**
- Fitbit steps (automatic)
- Clothes fit (more useful than daily weight)
- Farm work capacity
- Quarterly bloodwork (objective medical truth)

### Why This Works for Autism/ADHD
- Reduces executive function load (weekly not daily)
- Satisfies systemizing (still tracking patterns)
- Avoids all-or-nothing trap (missing a week doesn't break system)
- Focuses on outcomes (HbA1c is the real measure)
- Leverages existing habits (Fitbit, Monday injection checkpoint)
- Respects both traits (structure + grace for inconsistency)

---

## Clinical Priorities (January 2026)

### Priority 1: Start Ozempic (TONIGHT - Jan 12/13)
- First injection Monday evening January 13
- Monitor side effects weeks 1-4
- Focus on hydration (1.5-2L daily)
- Keep crackers available
- Monitor bowel movements

### Priority 2: Monitor Kidney Function
- Early microalbuminuria detected (urine albumin 22.7 vs normal <20)
- Recheck kidney function and urine albumin in 3 months

### Priority 3: Cholesterol Management
- Reduce LDL from 3.02 to <2.6 mmol/L
- Rosuvastatin daily, recheck lipids in 3 months

### Priority 4: Blood Pressure Monitoring
- Monitor BP on new Telmisartan HCTZ regimen

### Priority 5: Testosterone Review
- Revisit with Dr. Massaro Spring 2026 given high natural levels

---

## Medical Follow-up Schedule

### February/March 2026
- **Phone appointment** with Dr. Sharma (late Feb/early March)
- Purpose: Check Ozempic tolerance before issuing next prescription

### April 2026 (3 months post-medication)
- **In-person appointment** with Dr. Sharma
- **Bloodwork:**
  - HbA1c (assess Ozempic + Metformin effectiveness)
  - Lipid panel (assess Rosuvastatin effectiveness)
  - Comprehensive metabolic panel
  - Kidney function (eGFR, creatinine)
  - Urine albumin/creatinine ratio
  - Liver function tests
  - Fasting glucose

### Ongoing
- **Every 3 months:** Regular follow-up with bloodwork
- **Every 6 months:** Testosterone/PSA/prostate check with Dr. Massaro

### Home Monitoring
- Blood pressure readings (if available)
- Weight tracking (weekly, Monday mornings)
- Symptom diary for Ozempic side effects (brief notes)

---

## Immediate Action Items

### Before First Injection (Jan 13)
- ‚úÖ Review Tina's advice
- ‚úÖ Plan Monday evening injection timing
- ‚òê Purchase fresh glucose test strips (optional)
- ‚òê Stock crackers (nausea management)
- ‚òê Purchase Milk of Magnesia (constipation backup)
- ‚òê Order Fairlife protein shakes from Costco.ca
- ‚òê Buy almonds and walnuts for protein snacking
- ‚òê Restock Over-50 multivitamin from Costco

### First Week Priorities
- Take first injection Monday evening
- Monitor for side effects (especially GI)
- Focus on hydration (1.5-2L plain water daily)
- Have crackers available at all times
- Monitor bowel movements

---

## Health Data Files

### Current Documents
- `patient_summary_jan2026.md` - This comprehensive summary (CURRENT)
- `patient_summary_jan2026.json` - Structured patient data
- `medications_jan2026.json` - Complete medication list
- `bloodwork_comprehensive_jan2026.json` - All lab results with trends
- `health_timeline_jan2026.json` - Chronological health events

### Historical/Reference Documents
- `ozempic-therapy-tracking.md` - Original Ozempic therapy document (replaced by this summary)
- `Consolidating_Health_Data.md` - Health data consolidation strategies
- `Health_coaching_questions.md` - Health coaching framework
- `diet-health.md` - Diet and nutrition notes

---

## Document History
- **Created:** January 12, 2026
- **Sources:** Consolidated from patient_summary_jan2026.md + ozempic-therapy-tracking.md
- **Next Review:** Weekly updates during Ozempic therapy; major review after 3-month bloodwork (April 2026)

---

**Clinical Note:** The 3.5-month period from September to December 2025 showed significant metabolic deterioration (HbA1c 6.5% ‚Üí 6.9%, microalbuminuria appearing), prompting comprehensive 5-drug regimen January 9, 2026. Ozempic initiation January 13 represents critical intervention for blood sugar control. Close monitoring over next 3-6 months essential to assess treatment effectiveness and manage potential side effects, particularly gout risk and muscle preservation during weight loss.